0 Comentários
0 Compartilhamentos
174 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Analyzing the Trastuzumab Biosimilars Market: Key Segments, Drivers, and Regional GrowthThe trastuzumab biosimilars market is shaped by a complex interplay of clinical need, regulatory environments, and regional healthcare economics. The trastuzumab biosimilars market is on a strong growth trajectory, projected to reach USD 2.5 billion by 2035. A detailed analysis of its segments and regional dynamics is essential for understanding its future direction. The market is...0 Comentários 0 Compartilhamentos 195 Visualizações 0 Anterior
-
Biosimilars Market Expansion Accelerated by Patent Expirations and Cost PressuresThe global pharmaceutical landscape is undergoing a major shift as patent expirations for blockbuster biological drugs open pathways for high-quality alternatives. According to market research on the Biosimilars Market, rising healthcare costs are pushing national health systems and insurers to encourage lower-cost biological treatments. Biosimilar therapies provide equivalent efficacy and...0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior
-
Biosimilars Market Trends Every Pharma Strategist Should WatchBiosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives to...0 Comentários 0 Compartilhamentos 56 Visualizações 0 Anterior
-
Biosimilars Market Trends Transforming the Global Biopharmaceutical Industry 2028Increasing clinical evidence is influencing the Biosimilars Market. Real-world experience, comparative studies, and post-market monitoring are contributing to a broader understanding of biosimilar performance across different patient populations. The Biosimilars Market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028, registering an estimated CAGR of...0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior
-
Breast Cancer Biologics: A Comprehensive Market Analysis of Trastuzumab BiosimilarsBreast cancer remains a leading cause of cancer-related deaths among women worldwide, with HER2-positive subtypes accounting for a significant portion of cases. The introduction of trastuzumab, a targeted biologic, revolutionized the treatment of this aggressive cancer. The subsequent development of breast cancer biologics in the form of trastuzumab biosimilars has expanded access to...0 Comentários 0 Compartilhamentos 317 Visualizações 0 Anterior
-
Key Generic Injectables Market Trends: Biosimilars, Prefilled Syringes, and Supply Chain ResilienceThe generic injectables sector is undergoing a period of significant transformation, driven by patent expirations, technological breakthroughs, and evolving healthcare needs. The latest Generic Injectables Market Trends reflect a clear move towards biosimilar injectables, the increasing adoption of prefilled syringes, and a strategic focus on supply chain resilience . Trend...0 Comentários 0 Compartilhamentos 406 Visualizações 0 Anterior
-
Oncology Biosimilars Market: Regional Analysis and Emerging OpportunitiesThe Oncology Biosimilars Market presents a diverse regional landscape with significant opportunities for biosimilar developers and healthcare stakeholders. Valued at USD 5.47 billion in 2024 and projected to reach USD 14.4 billion by 2035, the market's growth is influenced by varying regional dynamics, including cancer burden, regulatory frameworks, and economic development. While...0 Comentários 0 Compartilhamentos 248 Visualizações 0 Anterior
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek